Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Introduction

Adenofibroma is a rare benign Müllerian mixed tumor composed of epithelial and mesenchymal cells. This tumor may occasionally be associated with toremifene therapy which is used as an adjuvant drug for breast cancer.

Case Presentation

We describe a case of a 55-year-old woman with adenofibroma of the endometrium. This patient was receiving toremifene after surgery and neoadjuvant chemotherapy for breast cancer. She underwent a total abdominal hysterectomy and bilateral salpingectomy. There was no evidence of tumor residual or recurrence at 32 months of MRI follow-up.

Conclusion

In conclusion, we report a rare case of endometrial adenofibroma in a patient receiving toremifene. It must be borne in mind that long-term toremifene therapy may increase the frequency of endometrial neoplasms.

© 2024 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmir/10.2174/1573405620666230426143620
2023-06-26
2024-11-26
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/CMIR-20-E260423216211.html?itemId=/content/journals/cmir/10.2174/1573405620666230426143620&mimeType=html&fmt=ahah

References

  1. ZaloudekC.J. NorrisH.J. Adenofibroma and adenosarcoma of the uterus: A clinicopathologic study of 35 cases.Cancer198148235436610.1002/1097‑0142(19810715)48:2<354::AID‑CNCR2820480222>3.0.CO;2‑Q6263458
    [Google Scholar]
  2. WatanabeH. HaradaN. NobuharaI. HarutaN. HigashiuraY. WatanabeS. Magnetic resonance imaging and flexible hysterofiberscopic findings of a uterine adenofibroma: Case report and literature review.Case Rep. Obstet. Gynecol.201820181810.1155/2018/968568329670786
    [Google Scholar]
  3. ReaD. PooleC. GrayR. Adjuvant tamoxifen: how long before we know how long?BMJ199831671431518151910.1136/bmj.316.7143.15189582148
    [Google Scholar]
  4. KennedyM. BaigrieC. ManekS. Tamoxifen and the endometrium: Review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.Int. J. Gynecol. Pathol.199918213013710202670
    [Google Scholar]
  5. VogelC.L. JohnstonM.A. CapersC. BracciaD. Toremifene for breast cancer: A review of 20 years of data.Clin. Breast Cancer20141411910.1016/j.clbc.2013.10.01424439786
    [Google Scholar]
  6. OberW.B. Uterine sarcomas: Histogenesis and taxonomy.Ann. N.Y. Acad. Sci.1959752 The Uterus56858510.1111/j.1749‑6632.1959.tb44576.x14428153
    [Google Scholar]
  7. PaganiO. GelberS. PriceK. ZahriehD. GelberR. SimonciniE. Castiglione-GertschM. CoatesA.S. GoldhirschA. Toremifene and tamoxifen are equally effective for early-stage breast cancer: First results of international breast cancer study group trials 12-93 and 14-93.Ann. Oncol.200415121749175910.1093/annonc/mdh46315550579
    [Google Scholar]
  8. LewisJ.D. ChagparA.B. ShaughnessyE.A. NurkoJ. McMastersK. EdwardsM.J. Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer.Cancer2010116102307231510.1002/cncr.2494020209619
    [Google Scholar]
  9. ZhouW.B. DingQ. ChenL. LiuX.A. WangS. Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: Results of four randomized trials.Breast Cancer Res. Treat.2011128362563110.1007/s10549‑011‑1556‑521553116
    [Google Scholar]
  10. ChungY.W. BaeH.S. HanS.I. SongJ.Y. KimI.S. KangJ.S. Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: A case report.J. Gynecol. Oncol.201021426927210.3802/jgo.2010.21.4.26921278890
    [Google Scholar]
  11. HuangK.T. ChenC.A. ChengW.F. WuC.C. JouH.J. HsiehC.Y. LinG.J. HsiehF.J. Sonographic characteristics of adenofibroma of the endometrium following tamoxifen therapy for breast cancer: Two case reports.Ultrasound Obstet. Gynecol.19967536336610.1046/j.1469‑0705.1996.07050363.x8774105
    [Google Scholar]
  12. OshimaH. MiyagawaH. SatoY. SatakeM. ShirakiN. NishikawaH. ArakawaA. OginoH. HaraM. Adenofibroma of the endometrium after tamoxifen therapy for breast cancer: MR findings.Abdom. Imaging200227559259410.1007/s00261‑001‑0098‑412173004
    [Google Scholar]
  13. IkutaA. TanakaY. MizokamiT. TsutsumiA. SatoM. TanakaM. Benign endometrial adenofibroma and polyp in patients receiving tamoxifen: Findings on transvaginal ultrasonography and magnetic resonance imaging.2005J. Med. Ultrason.322717610.1007/s10396‑005‑0036‑027277125
    [Google Scholar]
  14. HayasakaK. MoritaK. SaitohT. TanakaY. Uterine adenofibroma and endometrial stromal sarcoma associated with tamoxifen therapy: MR findings.Comput. Med Imaging Graph.200630531531816890405
    [Google Scholar]
  15. ShiH. ChenX. LvB. ZhangX. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.Int. J. Clin. Exp. Pathol.2015811153811538526823898
    [Google Scholar]
  16. LeeH.K. KimS.H. ChoJ.Y. YeonK.M. Uterine adenofibroma and adenosarcoma: CT and MR findings.J. Comput. Assist. Tomogr.199822231431610.1097/00004728‑199803000‑000309530402
    [Google Scholar]
  17. AriciD.S. AkerH. YildizE. TasyurtA. Mullerian adenosarcoma of the uterus associated with tamoxifen therapy.Arch. Gynecol. Obstet.2000264210510710.1007/s00404000008011045336
    [Google Scholar]
  18. GallardoA. PratJ. Mullerian adenosarcoma.Am. J. Surg. Pathol.200933227828810.1097/PAS.0b013e318181a80d18941402
    [Google Scholar]
  19. FelixA.S. WeissfeldJ.L. StoneR.A. BowserR. ChivukulaM. EdwardsR.P. LinkovF. Factors associated with Type I and Type II endometrial cancer.Cancer Causes Control201021111851185610.1007/s10552‑010‑9612‑820628804
    [Google Scholar]
  20. GraselR.P. OutwaterE.K. SiegelmanE.S. CapuzziD. ParkerL. HussainS.M. Endometrial polyps: MR imaging features and distinction from endometrial carcinoma.Radiology20002141475210.1148/radiology.214.1.r00ja364710644100
    [Google Scholar]
/content/journals/cmir/10.2174/1573405620666230426143620
Loading
/content/journals/cmir/10.2174/1573405620666230426143620
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test